---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-115077"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2021-09-13T23:59:59+00:00"
generated_at: "2026-06-29T04:02:58.940146+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Eloxx Pharmaceuticals presents at H.C. Wainwright 23rd Annual Global Investment Conference

## Summary
- Presentation scheduled for September 13–15, 2021; materials available on company website.
- No financial results, guidance, or material disclosures included in the filing.
- Routine investor conference presentation with no specific new information provided.

## SEC filing metadata
- accession: 0001104659-21-115077
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2021-09-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465921115077/0001104659-21-115077-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465921115077/tm2127509d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-115077
- JSON: https://secwatch.observer/filing/0001104659-21-115077.json
- Plain text: https://secwatch.observer/filing/0001104659-21-115077.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.